Search - tctmd.com

Displaying 21 - 33 of 33

Sort: Relevancy | Date

Presentation TCT 2017

Critical Limb Ischemia Update, and the STOP-PAD Trial

Presenter: Timothy D. Henry, Marc S. Penn, Mehdi H. Shishehbor

October 31, 2017

Presentation TCT 2017

New Strategies: Repetitive Injections

Presenter: Timothy D. Henry, Marc S. Penn, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

New Trials: REGENT-VSEL

Presenter: Timothy D. Henry, Marc S. Penn, Wojtek Wojakowski

October 31, 2017

$Special Lecture: Treatment of Refractory Angina - Reducer-1 European Registry and US Approval Trial (With Discussion)$

Presentation TCT 2017

Special Lecture: Treatment of Refractory Angina - Reducer-1 European Registry and US Approval Trial (With Discussion)

Presenter: Philippe Genereux, Simon J. Walsh, Stefan Verheye

October 30, 2017

$The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina$

Presentation JIM 2017

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

Presenter: Francesco Giannini

February 10, 2017

$Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!$

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

$Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina$

Presentation TCT 2015

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Presenter: Greg L. Kaluza, Joachim Schofer, Timothy D. Henry

October 15, 2015

$Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina$

Presentation

Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina

Presenter: S. Verheye

February 03, 2015

$Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO$

Presentation TCT 2013

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

Presenter: Timothy Henry

October 29, 2013

$The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...$

Presentation TCT 2013

The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...

Presenter: Shmuel Banai, Marc Jolicoeur, Jean-Fran?ois Tanguay, Elazer Edelman, Stefan Verheye

January 31, 2013

$Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up$

Presentation Cell Therapy 2013

Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up

Presenter: Anders Bruun Mathiasen

January 23, 2013

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

$Mobilized CD 34+ Cells for Refractory Angina$

Presentation TCT 2012

Mobilized CD 34+ Cells for Refractory Angina

Presenter: Thomas Povsic

October 22, 2012

Advertisement

Critical Limb Ischemia Update, and the STOP-PAD Trial

New Strategies: Repetitive Injections

New Trials: REGENT-VSEL

Special Lecture: Treatment of Refractory Angina - Reducer-1 European Registry and US Approval Trial (With Discussion)

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...

Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Mobilized CD 34+ Cells for Refractory Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content